ページ4 - 最高の腎癌医師 - トップ103名の医師

医師は30年以上の経験を持つ免疫学者であり、免疫学の最先端分野であるウイルス療法を専門としています。 <\/p>

リガ医科大学を卒業し、内科でのインターンシップを修了しました。 <\/p>

現在、Pauls Stradins Clinical University Hospitalの臨床免疫学センターの責任者を務めています。<\/p>

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Oncosurgeon, Head of Samsung Department of Urology

Dr. Vladimir Yutkin Vladimir Yutkin is a highly experienced doctor at the Hadassah Medical Center, with over 20 years of experience. Key takeaways:

• Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel) in 1996;
• Over 20 years of experience;
• Specialty is diagnosis and treatment of temporomandibular joint disorders;
• Speaks English, Hebrew, and Russian.

Head of the Urology Department, Oncosurgeon

Urologist, Oncosurgeon

プロフェッサー ドクター エドゥアルド・ベヒトはドイツで41年の経験を持つ泌尿器科医であり、アテネのカポディアストリアス大学から名誉博士号を授与されています。彼の主なポイントは以下の通りです:

• "フランクフルト・アム・マイン eV インターディシプリナリー ユロオンコロジー" 協会の会長
• 1972年にマインツのヨハネス グーテンベルク大学を卒業
• 1980年に同大学の医療クリニック、腎臓病学科で博士号を取得
• 1994年からフランクフルト・アム・マインのゲーテ大学で講師を務める
• 泌尿器科腫瘍学、前立腺癌の低侵襲治療、臓器保存腎腫瘍手術、前立腺腺腫の治療、再建泌尿器科、尿道手術、小児泌尿器科、腎臓結石治療などの分野に注力
• 彼のクレジットに100以上の科学論文がある

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

Medical Intrests

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Stomach Cancer
• Rectal Cancer
• Ovarian Cancer
• Liver Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Kidney Cancer
• Larynx Cancer - Cancer of the Larynx
• Thyroid Cancer
• Head and Neck Cancers
• Gynaecological Cancers
• Pancreatic Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Uterine Cancer
• Brain Cancers - Brain Tumours
• Soft Tissue Cancer - Sarcomas
• Prostate Cancer
• Bladder Cancer
• Bile Tract Cancer
• Testicular Cancer
• Cervical Cancer
• Mouth, Tongue, Lip Cancers
• Gastrointestinal System Cancers
• Bone Tumours
• Trachea and Bronchial Cancers
• Skin Cancers - Skin Cancers
• Skeletal System Tumours
• Gallbladder Cancer
• Mesothelioma

外科治療：泌尿器科におけるすべての手術。

医療サービスの一般管理。患者のポリクリニック受診。評議会への参加。難しいケースにおける「セカンドオピニオン」、臨床状況の専門評価。マスタークラス、ワークショップ、ウェブセミナーの組織と開催。

医師が持つ技術：

前立腺のTUIPおよび膀胱形成のTOIP。

前立腺のレーザー摘除、膀胱腫瘍のレーザー切解。

前立腺腺のレーザー蒸発。

尿道狭窄のレーザー切開

接触レーザー尿管-、腎盂-および膀胱結石破砕

経皮（ミニ）腎結石破砕術

腎内逆行性および前進手術（RIRSおよびAIRS）ボアリ手術。

損傷または狭窄の場合の尿道形成術

膀胱経由の前立腺切除術

膀胱造瘻術 - 開放型およびトロカー

腎瘻

根治的腎摘出術（腹腔鏡を含む）

腎破裂の縫合

腎盂切石術

尿管切石術

骨盤尿管形成術（腹腔鏡）

腎嚢胞の除去（嚢胞切除術）（腹腔鏡）

尿管膀胱吻合術

尿管皮膚瘻造設術

膀胱の腹腔内および後腹膜破裂に対する手術

去勢術

副睾丸切除術

ベルクマンおよびウィンケルマン手術

外傷および炎症性疾患によるポルチコ器官の修正

静脈瘤、割礼、経皮腎瘻、腎結石破砕のためのイバニセビッチおよびマルマール手術

腎嚢胞の穿刺

Marmara University Faculty of Medicine, Department of Radiation Oncology Specialization training: 2012 -2016

Marmara University Faculty of Medicine (English) Undergraduate: 2004-2011

Sixteen Numbered Shirvan School (Azerbaijan) High School: 1998 -2004

(現代甲状腺学と腹腔鏡手術)。

ケマル・ラシャ博士は、アナドル医療センター、コジャエリの経験豊富な一般外科医であり、彼の専門分野で23年の経験を有しています。彼の主なポイントは次のとおりです：

• 一般外科、手術感染症、乳がん、甲状腺/副甲状腺手術、高度な低侵襲手術、膵臓がん、グルコース代謝を専門とする
• 1990年にハジェッテペ大学医学部を卒業
• 1996年にハジェッテペ大学医学部で一般外科の専門訓練を受けた
• ヨーロッパ手術感染症学会、世界手術感染症学会、世界緊急手術学会、トルコ医学会、トルコ外科学会を含む様々な団体との積極的な提携
• 彼の功績となる出版物がある。

医学的関心と活動 

• 泌尿器がん学 • ロボット支援腹腔鏡泌尿器手術 • 腹腔鏡的泌尿器科 • 経皮的腎手術 • 内視鏡的泌尿器科 • 泌尿婦人科学

会員資格 

• トルコ泌尿器学会 • 内視鏡泌尿器科学会 • トルコ男科学学会 • 内視鏡泌尿器科協会 • ヨーロッパ泌尿器科学会 (EAU) • アメリカ泌尿器科学会 (AUA) 

研究および出版物 

• 31件の国際出版物 • 22件の国内出版物 • 2件のトルコの書籍セクション • 71件の国際および国内通知